HIV-1 reverse transcriptase
E1237554
UNEXPLORED
HIV-1 reverse transcriptase is a viral enzyme that converts the HIV-1 RNA genome into DNA, making it a key target for antiretroviral drugs used in HIV treatment.
All labels observed (1)
| Label | Occurrences |
|---|---|
| HIV-1 reverse transcriptase canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T16852017 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: HIV-1 reverse transcriptase Context triple: [Biktarvy, target, HIV-1 reverse transcriptase]
-
A.
HIV-1 integrase
HIV-1 integrase is a viral enzyme that inserts HIV-1’s genetic material into the host cell’s DNA, making it a key target for antiretroviral drugs.
-
B.
HIV-1
HIV-1 is the primary virus responsible for the global HIV/AIDS pandemic, characterized by its rapid mutation and attack on the human immune system’s CD4+ T cells.
-
C.
Baltimore classification of viruses
The Baltimore classification of viruses is a system that groups viruses into seven classes based on their type of nucleic acid and replication strategy, providing a framework for understanding viral genetics and life cycles.
-
D.
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
E.
Cohen–Boyer recombinant DNA patents
The Cohen–Boyer recombinant DNA patents were foundational biotechnology patents that covered key methods for creating recombinant DNA, enabling modern genetic engineering and the biotechnology industry.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: HIV-1 reverse transcriptase Target entity description: HIV-1 reverse transcriptase is a viral enzyme that converts the HIV-1 RNA genome into DNA, making it a key target for antiretroviral drugs used in HIV treatment.
-
A.
HIV-1 integrase
HIV-1 integrase is a viral enzyme that inserts HIV-1’s genetic material into the host cell’s DNA, making it a key target for antiretroviral drugs.
-
B.
HIV-1
HIV-1 is the primary virus responsible for the global HIV/AIDS pandemic, characterized by its rapid mutation and attack on the human immune system’s CD4+ T cells.
-
C.
Baltimore classification of viruses
The Baltimore classification of viruses is a system that groups viruses into seven classes based on their type of nucleic acid and replication strategy, providing a framework for understanding viral genetics and life cycles.
-
D.
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
E.
Cohen–Boyer recombinant DNA patents
The Cohen–Boyer recombinant DNA patents were foundational biotechnology patents that covered key methods for creating recombinant DNA, enabling modern genetic engineering and the biotechnology industry.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.